HORIBA, Ltd.

Tokyo Stock Exchange 6856.T

HORIBA, Ltd. Gross Profit Margin for the year ending December 31, 2023: 43.84%

HORIBA, Ltd. Gross Profit Margin is 43.84% for the year ending December 31, 2023, a 1.50% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • HORIBA, Ltd. Gross Profit Margin for the year ending December 31, 2022 was 43.19%, a 3.93% change year over year.
  • HORIBA, Ltd. Gross Profit Margin for the year ending December 31, 2021 was 41.56%, a 1.72% change year over year.
  • HORIBA, Ltd. Gross Profit Margin for the year ending December 31, 2020 was 40.86%, a -0.98% change year over year.
  • HORIBA, Ltd. Gross Profit Margin for the year ending December 31, 2019 was 41.26%, a -3.40% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Loading...
Tokyo Stock Exchange: 6856.T

HORIBA, Ltd.

CEO Mr. Atsushi Horiba
IPO Date Jan. 1, 2001
Location Japan
Headquarters 2 Miyanohigashi
Employees 8,665
Sector Consumer Discretionary
Industries
Description

HORIBA, Ltd. manufactures and sells instruments and systems for various applications. It operates in five segments: Automotive, Process & Environmental, Medical-Diagnostic, Semiconductor, and Scientific. The Automotive segment offers automotive emission analyzers, emission measurement systems, drive line test systems, engine test and fuel cell test systems, and battery test systems; test systems for engines, chassis, powertrains, brakes, and catalysts; and vehicle development engineering and testing engineering services, as well as leases and manages R&D facilities. The Process & Environmental segment provides stack gas analyzers, industrial water quality analyzers, water quality analysis and examination systems, air pollution analyzers, environmental radiation meters, and process measurement equipment. The Medical-Diagnostic segment offers hematology and CRP, immunology, clinical chemistry, and blood glucose analyzers. The Semiconductor Instruments & Systems segment provides mass flow controllers, chemical concentration monitors, reticle/mask particle detection systems, residual gas analyzers, and vaporizers. The Scientific segment offers Raman spectrometers, pH meters, particle-size distribution analyzers, X-Ray fluorescence analyzers, elemental analyzers, fluorescence spectroscopy/fluorescence lifetime spectroscopy, optical components, spectrometers and detectors, and gratings. The company was founded in 1945 and is headquartered in Kyoto, Japan.

Similar companies

6645.T

OMRON Corporation

USD 30.09

-1.00%

7701.T

Shimadzu Corporation

USD 27.11

-0.51%

6728.T

ULVAC, Inc.

USD 38.60

-2.69%

6965.T

Hamamatsu Photonics K.K.

USD 11.61

2.96%

6479.T

MINEBEA MITSUMI Inc.

USD 15.39

-1.56%

StockViz Staff

January 15, 2025

Any question? Send us an email